← Back to Search

Stigma Reduction Strategies for HIV Prevention Engagement

N/A

Waitlist Available

Led By Bryan Kutner, PhD, MPH

Research Sponsored by Bryan Kutner

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

have had anal intercourse with a man in the past year or intend to in the next year

report being assigned male at birth and identifying currently as male

Timeline

Screening 3 weeks

Treatment Varies

Follow Up (1) the 3-month period pre-intervention, (2) the 3-month period during intervention, and then (3) the 3-month post-intervention, up to 9 months total.

Awards & highlights

No Placebo-Only Group

Summary

This trial is to find out how to make healthcare workers more comfortable with anal sex so that gay and bisexual men will be more likely to get HIV-related services.

Who is the study for?

This trial is for males assigned at birth, currently identifying as male, living in the U.S., who have had or plan to have anal intercourse with a man within a year. Participants must be 18+, able to read and communicate in English, and interested in HIV-related services.

What is being tested?

The study is testing strategies to reduce sexual stigma by healthcare workers towards gay and bisexual men. The goal is to improve these men's engagement in HIV prevention services through developing and piloting an intervention for health professionals.

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not expected. However, participants may experience emotional or psychological responses during the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had or plan to have anal intercourse with a man within a year.

Select...

I was assigned male at birth and identify as male.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ (1) the 3-month period pre-intervention, (2) the 3-month period during intervention, and then (3) the 3-month post-intervention, up to 9 months total.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~(1) the 3-month period pre-intervention, (2) the 3-month period during intervention, and then (3) the 3-month post-intervention, up to 9 months total.

This trial's timeline: 3 weeks for screening, Varies for treatment, and (1) the 3-month period pre-intervention, (2) the 3-month period during intervention, and then (3) the 3-month post-intervention, up to 9 months total. for reporting.